{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:14:00Z","timestamp":1778897640947,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2022\/13216\\u20130"],"award-info":[{"award-number":["2022\/13216\\u20130"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2023\/03765\\u20130"],"award-info":[{"award-number":["2023\/03765\\u20130"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2633\/23"],"award-info":[{"award-number":["2633\/23"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006417","name":"State University of Campinas Teaching Research and Extension Support Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.htct.2025.106227","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:02:14Z","timestamp":1766181734000},"page":"106227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma levels of soluble podoplanin are higher in acute promyelocytic leukemia compared to other forms of acute myeloid leukemia"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6871-7097","authenticated-orcid":false,"given":"Carla Roberta Peachazepi","family":"Moraes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla Maria de Alencar","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivanio Teixeira","family":"Borba-Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-3253","authenticated-orcid":false,"given":"Bruno Kosa Lino","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Melo","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0809-8068","authenticated-orcid":false,"given":"Sara Teresinha Olalla","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1539-7912","authenticated-orcid":false,"given":"Erich Vinicius","family":"De Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2025.106227_bib0001","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","author":"Meng-er","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106227_bib0002","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha\/PML proteins","volume":"88","author":"Chen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106227_bib0003","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","article-title":"Management of acute promyelocytic leukemia: Updated recommendations from an expert panel of the European LeukemiaNet","volume":"133","author":"Sanz","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106227_bib0004","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1182\/blood-2011-04-346437","article-title":"Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid","volume":"118","author":"Park","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106227_bib0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/jth.13590","article-title":"Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood","volume":"15","author":"Suzuki-Inoue","year":"2017","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.htct.2025.106227_bib0006","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.thromres.2018.01.020","article-title":"The role of podoplanin in cancer-associated thrombosis","volume":"164","author":"Mir Seyed Nazari","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.htct.2025.106227_bib0007","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1182\/bloodadvances.2020002998","article-title":"Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles","volume":"5","author":"Tawil","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.htct.2025.106227_bib0008","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41375-018-0069-1","article-title":"Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin","volume":"32","author":"Lavall\u00e9e","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.htct.2025.106227_bib0009","first-page":"1","article-title":"Prospective validation of podoplanin expression as a diagnostic biomarker of acute promyelocytic leukemia","author":"Saraiva CM de","year":"2025","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.htct.2025.106227_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.htct.2025.106227_bib0011","first-page":"1","article-title":"Biomarkers and point of care screening approaches for the management of preeclampsia","volume":"4","author":"Ng","year":"2024","journal-title":"Communications Medicine. Springer Nature"},{"key":"10.1016\/j.htct.2025.106227_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0153508","article-title":"Serum uPAR as biomarker in breast cancer recurrence: A mathematical model","volume":"11","author":"Hao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.htct.2025.106227_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13205100","article-title":"The soluble urokinase-type plasminogen activator receptor as a biomarker for survival and early treatment effect in metastatic colorectal cancer","volume":"13","author":"Blomberg","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.htct.2025.106227_bib0014","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cas.13475","article-title":"Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis","volume":"109","author":"Zhao","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.htct.2025.106227_bib0015","doi-asserted-by":"crossref","first-page":"13207","DOI":"10.2147\/CMAR.S281785","article-title":"The detection of plasma soluble podoplanin of patients with breast cancer and its clinical signification","volume":"12","author":"Zhu","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.htct.2025.106227_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2022.8262","article-title":"Soluble podoplanin as a biomarker in diffusetype gastric cancer","volume":"47","author":"Takiguchi","year":"2022","journal-title":"Oncol Rep"},{"key":"10.1016\/j.htct.2025.106227_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10760296231183432","article-title":"Plasma Soluble Podoplanin as a Biomarker of Hypercoagulability and Cellular Immunity Status in Patients With Non-small Cell Lung Cancer","volume":"29","author":"Zhang","year":"2023","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.htct.2025.106227_bib0018","first-page":"1","article-title":"Podoplanin and CLEC-2 levels in patients with COVID-19","volume":"7","author":"IT","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.htct.2025.106227_bib0019","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1182\/blood-2016-10-747170","article-title":"Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era","volume":"129","author":"Mantha","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106227_bib0020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/hematology.2023000477","article-title":"How to avoid early mortality in acute promyelocytic leukemia","author":"Odetola","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.htct.2025.106227_bib0021","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/ATVBAHA.115.307074","article-title":"Platelet CD40 exacerbates atherosclerosis by transcellular activation of endothelial cells and leukocytes","volume":"36","author":"Gerdes","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.htct.2025.106227_bib0022","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 ligand","volume":"67","author":"Van Kooten","year":"2000","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.htct.2025.106227_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.825892","article-title":"Platelets as Key Factors in Inflammation: focus on CD40L\/CD40","volume":"13","author":"Cognasse","year":"2022","journal-title":"Front Immunol"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925024927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925024927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:58:24Z","timestamp":1778896704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137925024927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2531137925024927"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2025.106227","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma levels of soluble podoplanin are higher in acute promyelocytic leukemia compared to other forms of acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2025.106227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106227"}}